Sequencing technology critical to identifying mutations of the virus, important for epidemiologists when tracking the spread of infections through a population BLOOMINGTON, MN, and SAN JOSE, CA – SkyWater Technology, the innovator’s trusted foundry partner, announced its partnership with MGI (a member of BGI Group) to supply critical components used by MGI’s DNA sequencing system DNBSEQ-T7, one of the first officially [...]

HOUSTON -- NuProbe Global, a global molecular diagnostics company based in Shanghai and Suzhou, China and Houston, TX, today announced it has entered into a collaboration agreement with QIAGEN to develop next-generation sequencing (NGS)-based cancer diagnostic tests for non-invasive liquid biopsy. Under terms of the collaboration agreement, NuProbe and QIAGEN will explore integrating their two amplicon-based enrichment and sequencing technologies: NuProbe's [...]

Arima Genomics, Inc., a biotechnology company focused on accelerating the adoption of genome structure information toward medical research, diagnosis and therapy, announced today the full commercial launch of the HiChIP application built on its existing Arima-HiC platform. With this launch, researchers can now obtain long-range chromatin interactions specifically enriched at genomic locations occupied by proteins [...]

CORALVILLE, Iowa – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, today announced its success in large-scale manufacturing of a key component used to enable testing of millions of Americans for COVID-19. IDT’s key component is a primer and probe kit, which assists in DNA analysis of patient samples. As of March 9, IDT had [...]

Enhanced digital strategy increases lab efficiencies and productivity SANTA CLARA, Calif -- Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for laboratories seeking increased visibility and control over operations. Today organizations struggle optimizing laboratory operation and asset management. Across large instrument fleets it [...]

AMSBIO announce the availability of recombinant proteins and antibodies for detection of Coronavirus (COVID-19) and related RNA viruses. Historically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains - SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of [...]

Speed and scale of Fluidigm microfluidics technology to facilitate early-stage host monitoring for COVID-19 SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that a consortium of medical schools led by the Icahn School of Medicine at Mount Sinai [...]

SOUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (Nasdaq: TWST) today announced the availability of Research-Use Only (RUO) target enrichment next-generation sequencing (NGS) panels for viral detection and characterization of samples from patients testing positive for SARS-CoV-2, the virus which causes COVID-19. These panels can be used for environmental monitoring and surveillance testing, while also providing [...]

Uppsala, Sweden: Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center of excellence providing advanced training to the bioprocessing industry, today announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will [...]

Mitsubishi Chemical Corporation (MCC; Head office: Chiyoda-ku, Tokyo Japan), a parent company of Mitsubishi Chemical Analytech Co., Ltd. (MCAT; Head office: Yamato, Kanagawa Japan), announced on 28th February 2020 an agreement to transfer MCAT’s entire business and assets to Nittoseiko Co., Ltd. (NSC: Head office; Ayabe, Kyoto, Japan) effective on 1st April 2020. The new [...]